We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results:1-10 of 667

Innovation key to driving success in healthcare
  • Boult Wade Tennant LLP
  • USA, United Kingdom
  • July 3 2018

As the NHS turns 70, it is notable that the focus for the future is on innovation for the improvement of patient care. Technologies spanning genetic

European data protection regulations - how Australian organisations may be affected
  • Arnold Bloch Leibler
  • Australia
  • May 1 2018

The European Union has introduced new wide-reaching data privacy regulations, which will come into effect from 25 May 2018 and are likely to impact

FDA Issues Two Guidances on Next Generation Sequencing
  • Reed Smith LLP
  • USA
  • April 24 2018

This guest post is from Reed Smith‘s Matt Jacobson, who is keeping us up to date with the FDA’s initiatives concerning pharmacogenomics and

FDA Guidance on Using Public Human Genetic Variant Databases for Genetic and Genomic-Based In Vitro Diagnostics
  • Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • USA
  • April 18 2018

On April 13, 2018, FDA issued final guidance on the Use of Public Human Genetic Variant Databases to Support Clinical Validity for Genetic and

FDA Authorizes First Direct-to-Consumer Genetic Test for Cancer
  • Arent Fox LLP
  • USA
  • March 14 2018

On March 6, 2018, the US Food and Drug Administration issued an authorization letter to 23andMe, Inc. that permits marketing of the company’s genetic

Seattle Genetics Acquires Cascadian Therapeutics, Continuing a Strong 2018 Start in Biotech Mergers and Acquisitions
  • Knobbe Martens
  • USA
  • February 12 2018

On January 31, two Seattle biotech companies, Seattle Genetics and Cascadian Therapeutics, announced a merger agreement under which Seattle Genetics

What’s the EEOC Up To These Days?
  • Barnes & Thornburg LLP
  • USA
  • January 30 2018

Are you curious as to what the EEOC has been up to in the past year? The wait is over in its 2017 Enforcement and Litigation Data released last

Declaration Submitted during IPR from Inventor of Prior Art Confirmed its Inherent Disclosure to Invalidate Monsanto’s Patent Claims
  • Hunton Andrews Kurth LLP
  • USA
  • January 5 2018

Monsanto appealed a Final Written Decision by the PTAB finding claims of U.S. Patent No. 7,790,953 (the “’953 patent) invalid in view of prior art in

Washington Healthcare Update - Nov 13, 2017
  • McGuireWoods LLP
  • USA
  • November 13 2017

Republicans are considering repealing the mandate that currently requires that most Americans obtain health coverage. The Republican House-proposed

Top 5 Tips for Conducting Pre-Employment Medical Exams
  • Jackson Lewis PC
  • USA
  • October 26 2017

In a recently filed lawsuit, the U.S. Equal Employment Opportunity Commission contends that Consolidated Edison Co. (“Con Ed”) violated the Americans